Bayer AG (BAYN.DE)
-XETRA 83.82 
0.33(0.40%) 11:35AM EDT
| Prev Close: | 83.49 |
|---|
| Open: | 83.12 |
|---|
| Bid: | 83.96 |
|---|
| Ask: | 84.00 |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 82.65 - 84.13 |
|---|
| 52wk Range: | 51.81 - 87.21 |
|---|
| Volume: | 1,484,131 |
|---|
| Avg Vol (3m): | 2,044,320 |
|---|
| Market Cap: | 69.31B |
|---|
| P/E (ttm): | 27.03 |
|---|
| EPS (ttm): | 3.10 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in EUR.
Headlines
- Arnold & Porter, Skadden, Cravath, Willkie: Business of Lawat Bloomberg(Tue 12:01AM EDT)
- Drugmakers Opened to ‘Pay for Delay’ Suits by High Courtat Bloomberg(Mon, Jun 17)
- J&J to Buy Aragon Pharmaceuticals for Cancer Candidateat Bloomberg(Mon, Jun 17)
- UK scientists win funding for new kind of anticoagulant drugat Reuters(Sun, Jun 16)
- Pfizer’s Two New Top Pills Selling Slower Than Expectedat Bloomberg(Thu, Jun 13)
- Eni’s Versalis Loses EU Top Court Appeal of Rubber Cartel Fineat Bloomberg(Thu, Jun 13)
- Shire’s New CEO Adds Sales Staff, Damps Takeover Talkat Bloomberg(Mon, Jun 10)
- Sanofi MS drug nears green light after pass-the-parcel marathonat Reuters(Mon, Jun 10)
- Monsanto Sued on Behalf of Farmers Over Modified Wheatat Bloomberg(Fri, Jun 7)
- MAN SE Chairman Expects Legal Battle Over VW Offer Priceat Bloomberg(Fri, Jun 7)
- Bayer say VEGF Trap-Eye shows promise as mCNV treatmentat Reuters(Thu, Jun 6)
- T-Mobile, Bayer, Monsanto, Boyd: Intellectual Propertyat Bloomberg(Thu, Jun 6)
- Bayer, Merck KGaA Sue Actavis Claiming Patent Violationat Bloomberg(Wed, Jun 5)
- Bayer completes offer for Conceptus sharesAP(Wed, Jun 5)
- Bayer says 96.4 pct of Conceptus shares tenderedat Reuters(Wed, Jun 5)
Reports
- No Reports available for BAYN.DE at this time.
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 1.73 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
()
: | N/A |
|---|
| Quarterly EPS Est
()
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Bayer Aktiengesellschaft develops, produces, and markets health care and agriculture products, and high-tech materials worldwide. The companys HealthCare segment provides pharmaceuticals, such as prescription pharmaceuticals for the treatmen...
View More